Mukai S, Fujisaki T, Sato N
Dept. of Surgery, Kosei General Hospital.
Gan To Kagaku Ryoho. 1995 Sep;22(11):1542-5.
We treated 8 patients of Stage III and IV breast cancer preoperatively with THP-ADR intra-arterial infusion chemotherapy. The median dose was 200 mg with a range from 150 to 310 mg. The response rate of THP was 75.0% compared to 66.7% of ADR. Leucopenia was observed during THP treatment with a lower frequency of alopecia.